Health Canada Approves InterCureÂ’s Breakthrough Therapeutic Breathing Device To Lower Blood Pressure
Millions of Canadians with high blood pressure can now benefit from the innovative non-drug medical device proven to lower blood pressure
(PRWEB) October 15, 2004 -
– Millions of Canadian with high blood pressure can now benefit from the first non-drug medical device clinically proven to reduce high blood pressure without side effects. InterCure, Inc. and Canadian partner, ManthaMed Inc., today announced that the device, RESPeRATE® has received clearance from the Health Canada and thereby joining the US, Europe, Korea and Israel health authorities which have already approved the use of the device.
The RESPeRATE device, already used by thousands of patients and doctors in the US, is based upon the established scientific evidence that certain breathing exercises with prolonged exhalation can lower blood pressure. These therapeutic breathing exercises are difficult to perform properly without the interactive, personalized coaching that RESPeRATE provides through its patented Respiratory Pacing technology.
The therapeutic powers of RESPeRATE have been validated by seven separate clinical trials which repeatedly found that within a few weeks of using the device for as little as 15 minutes a day, 3-4 times per week, a significant and sustained reduction in blood pressure could be obtained in addition to other treatment options such as medication, diet and exercise. For people with high blood pressure, most of whom were already taking medication, RESPeRATE lowered blood pressure by an average of 14 mmHg systolic and 9 mmHg diastolic, and up to 36/20 mmHg (top 10% reductions).
RESPeRATE clinical results have been published in leading medical journals such as the American Journal of Hypertension and recently been added to textbooks such as the American Heart AssociationÂ’s Hypertension Primer, and Mayo ClinicÂ’s On Hypertension. RESPeRATE is now available in Canada by calling ManthaMed at 1-800-728-7327 or online at http://www. resperate. ca (http://www. resperate. ca)
About InterCure
InterCure is a medical device company that creates and sells products that harness the therapeutic power of breathing for the treatment of hypertension, heart failure, respiratory diseases and other conditions.
The company has patented a fundamental “Interactive Respiratory Pacing” technology that has been validated in multiple comprehensive clinical trials and the technology has won the backing of world-renowned opinion leaders in the fields of hypertension and heart failure. InterCure’s product, RESPeRATE, is the first medical device ever to be cleared by the FDA for the treatment of hypertension. More information is available at www. intercure. com.
About ManthaMed
ManthaMed is a Canadian distributor of accurate and reliable monitoring and diagnostic medical devices. Several of these leading edge medical devices are used in hospitals, physician offices and pharmacies for the diagnosis and monitoring of diseases such as diabetes, hypertension, cholesterol disorders, weight management, osteoporosis and asthma.
The companyÂ’s mission is to improve patient access to early diagnosis and preventative care. More information is available at www. manthamed. com. RESPeRATE can be purchased online at www. resperate. ca.
Contacts:
ManthaMed: Peter Mantha
ManthaMed Inc.
1-800-728-7327
InterCure: Tom Kirwan
InterCure Inc.
201-720-7750 Ext.7136
# # #
